Sigyn Therapeutics, Inc. (SIGY)
Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. The company is headquartered in San Diego, California.
$7.27M
5.00
San Diego, CA
Jan 08, 2021
-1.88
$-3.06
0.00
0.04
0.00%
-1.44
-2.56
0.00
0.00
-1,492.14%
239.05%
Similar stocks (17)
Blueprint Medicines Corporation
BPMC
Vericel Corporation
VCEL
Keros Therapeutics, Inc.
KROS
Day One Biopharmaceuticals, Inc.
DAWN
Phathom Pharmaceuticals, Inc.
PHAT
Cullinan Oncology, Inc.
CGEM
Century Therapeutics, Inc.
IPSC
AlloVir, Inc.
ALVR
Aerovate Therapeutics, Inc.
AVTE
Lyra Therapeutics, Inc.
LYRA
Forte Biosciences, Inc.
FBRX
Molecular Templates, Inc.
MTEM
Protagenic Therapeutics, Inc.
PTIX
Peak Bio, Inc.
PKBO
Dermata Therapeutics, Inc.
DRMA
RespireRx Pharmaceuticals Inc.
RSPI
eFFECTOR Therapeutics, Inc.
EFTR
Similar stocks (17)
Blueprint Medicines Corporation
BPMC
Vericel Corporation
VCEL
Keros Therapeutics, Inc.
KROS
Day One Biopharmaceuticals, Inc.
DAWN
Phathom Pharmaceuticals, Inc.
PHAT
Cullinan Oncology, Inc.
CGEM
Century Therapeutics, Inc.
IPSC
AlloVir, Inc.
ALVR
Aerovate Therapeutics, Inc.
AVTE
Lyra Therapeutics, Inc.
LYRA
Forte Biosciences, Inc.
FBRX
Molecular Templates, Inc.
MTEM
Protagenic Therapeutics, Inc.
PTIX
Peak Bio, Inc.
PKBO
Dermata Therapeutics, Inc.
DRMA
RespireRx Pharmaceuticals Inc.
RSPI
eFFECTOR Therapeutics, Inc.
EFTR